<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8573121" created="07/07/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8573121</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Inhibition of <term id="T1" lex="NF-kappa_B_activation" sem="Other"><term id="T2" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> in <term id="T3" lex="human_T-cell_line" sem="Cell_cultured">human T-cell lines</term> by <term id="T4" lex="anetholdithiolthione" sem="Organic_compound_other">anetholdithiolthione</term>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<clue>Inhibition of NF-kappa B <clueType>activation</clueType> in human T-cell lines by anetholdithiolthione.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="T4"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation <clueLoc>in human T-cell lines</clueLoc> <linkCause>by</linkCause> anetholdithiolthione.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T5" lex="nuclear_factor_(NF)-kappa_B" sem="Protein_complex">Nuclear factor (NF)-kappa B</term> is a <term id="T6" lex="redox_sensitive_cytosolic_transcription_factor" sem="Protein_family_or_group"><term id="A1" sem="Other">redox</term> sensitive cytosolic transcription factor</term>.</sentence>
<event KT="Fact" id="E3">
<type/>
<theme idref="T5"/>
<cause idref="A1"/>
<clue>Nuclear factor (NF)-kappa B is a redox <clueType>sensitive</clueType> <corefTheme>cytosolic transcription factor</corefTheme>.</clue>
<comment>SENSITIVITY</comment></event>
<sentence id="S3"><term id="A2" sem="Other">Redox</term> regulation of <term id="T7" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> has been implicated in the activation of the <term id="T8" lex="human_immuno-deficiency_virus" sem="Virus">human immuno-deficiency virus</term> (<term id="T9" lex="HIV" sem="Virus">HIV</term>).</sentence>
<event KT="Other" id="E4">
<type class="Regulation"/>
<theme idref="T7"/>
<cause idref="A2"/>
<clue>Redox <clueType>regulation</clueType> <linkTheme>of</linkTheme> NF-kappa B has been implicated in the activation of the human immuno-deficiency virus (HIV).</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<clue>Redox regulation of NF-kappa B has been implicated in the <clueType>activation</clueType> <linkTheme>of</linkTheme> the human immuno-deficiency virus (HIV).</clue>
</event>
<event CL="L2" KT="Analysis" Source="Other" id="E6">
<type class="Correlation"/>
<theme idref="E5"/>
<theme idref="E4"/>
<clue>Redox regulation of NF-kappa B <clueSource>has been</clueSource> <clueType><clueKT><clueCL>implicated</clueCL></clueKT></clueType> <linkTheme>in</linkTheme> the activation of the human immuno-deficiency virus (HIV).</clue>
</event>
<sentence id="S4">Therefore, inhibition of <term id="T10" lex="NF-kappa_B_activation" sem="Other"><term id="T11" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> may be an effective strategy for <term id="T12" lex="acquired_immunodeficiency_syndrome_therapy" sem="Other"><term id="T13" lex="acquired_immunodeficiency_syndrome" sem="Other">acquired immunodeficiency syndrome</term> therapy</term>.</sentence>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<clue>Therefore, inhibition of NF-kappa B <clueType>activation</clueType> may be an effective strategy for acquired immunodeficiency syndrome therapy.</clue>
</event>
<event KT="Other" id="E8">
<type class="Negative_regulation"/>
<theme idref="E7"/>
<clue>Therefore, <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation may be an effective strategy for acquired immunodeficiency syndrome therapy.</clue>
</event>
<sentence id="S5"><term id="T14" lex="anetholdithiolthione" sem="Organic_compound_other">Anetholdithiolthione</term> (<term id="T15" lex="ADT" sem="Organic_compound_other">ADT</term>, <term id="T16" lex="5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione" sem="Organic_compound_other">5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione</term>) is an <term id="T17" lex="antioxidant" sem="Organic_compound_other">antioxidant</term> which has been used to protect against <term id="A4" sem="Organic_compound_other">acetaminophen</term>- and <term id="A5" sem="Inorganic_compound">CCl4</term>-induced <term id="A6" sem="Other">hepatotoxicity</term>, <term id="T19" lex="lipid_peroxidation" sem="Other"><term id="T20" lex="lipid" sem="Lipid">lipid</term> peroxidation</term>, <term id="T21" lex="radiation_injury" sem="Other">radiation injury</term>, and also has been used clinically as an <term id="T22" lex="anti-choleretic_agent" sem="Organic_compound_other">anti-choleretic agent</term>.</sentence>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="A4"/>
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to protect against acetaminophen- and CCl4-<clueType>induced</clueType> hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
<comment>NER: T18 DEL</comment></event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="A5"/>
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to protect against acetaminophen- and CCl4-<clueType>induced</clueType> hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="T15"/>
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to <clueType>protect</clueType> <linkTheme>against</linkTheme> acetaminophen- and CCl4-induced hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Negative_regulation"/>
<theme idref="E10"/>
<cause idref="T15"/>
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to <clueType>protect</clueType> <linkTheme>against</linkTheme> acetaminophen- and CCl4-induced hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<event KT="Fact" id="E13">
<type class="Negative_regulation"/>
<theme idref="T19"/>
<cause idref="T15"/>
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to <clueType>protect</clueType> <linkTheme>against</linkTheme> acetaminophen- and CCl4-induced hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<event KT="Fact" id="E14">
<type class="Negative_regulation"/>
<theme idref="T21"/>
<cause idref="T15"/>
<clue>Anetholdithiolthione (ADT, 5-[p-methoxyphenyl]-3H-1,2-dithiol-3-thione) is an antioxidant which has been used to <clueType>protect</clueType> <linkTheme>against</linkTheme> acetaminophen- and CCl4-induced hepatotoxicity, lipid peroxidation, radiation injury, and also has been used clinically as an anti-choleretic agent.</clue>
</event>
<sentence id="S6">The present study examined the effect of <term id="T23" lex="ADT_pretreatment" sem="Other"><term id="T24" lex="ADT" sem="Organic_compound_other">ADT</term> pretreatment</term> on <term id="T25" lex="NF-kappa_B_activation" sem="Other"><term id="T26" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> in response to a variety of stimuli such as <term id="T27" lex="H2O2" sem="Inorganic_compound">H2O2</term>, <term id="T28" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term> (<term id="T29" lex="PMA" sem="Organic_compound_other">PMA</term>) or <term id="T30" lex="tumor_necrosis_factor_alpha" sem="Protein_molecule">tumor necrosis factor alpha</term> (<term id="T31" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term>).</sentence>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<cause idref="T27"/>
<clue>The present study examined the effect of ADT pretreatment on NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<cause idref="T29"/>
<clue>The present study examined the effect of ADT pretreatment on NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<cause idref="T31"/>
<clue>The present study examined the effect of ADT pretreatment on NF-kappa B <clueType>activation</clueType> <linkCause>in response to</linkCause> a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event KT="Method" id="E18">
<type class="Artificial_process"/>
<theme idref="T24"/>
<clue>The present study examined the effect of ADT <clueType>pretreatment</clueType> on NF-kappa B activation in response to a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event KT="Investigation" id="E19">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="E18"/>
<clue>The present study <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> ADT pretreatment <linkTheme>on</linkTheme> NF-kappa B activation in response to a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event KT="Investigation" id="E20">
<type class="Regulation"/>
<theme idref="E16"/>
<cause idref="E18"/>
<clue>The present study <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> ADT pretreatment <linkTheme>on</linkTheme> NF-kappa B activation in response to a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<event KT="Investigation" id="E21">
<type class="Regulation"/>
<theme idref="E17"/>
<cause idref="E18"/>
<clue>The present study <clueKT>examined</clueKT> the <clueType>effect</clueType> <linkCause>of</linkCause> ADT pretreatment <linkTheme>on</linkTheme> NF-kappa B activation in response to a variety of stimuli such as H2O2, phorbol myristate acetate (PMA) or tumor necrosis factor alpha (TNF alpha).</clue>
</event>
<sentence id="S7"><term id="T32" lex="PMA" sem="Organic_compound_other">PMA</term> and <term id="T33" lex="TNF_alpha_induced_activation" sem="Other"><term id="T34" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term> induced activation</term> of <term id="T35" lex="(NF)-kappa_B" sem="Protein_complex">(NF)-kappa B</term> in human <term id="T36" lex="Jurkat_T-cell" sem="Cell_cultured">Jurkat T-cells</term> was partially inhibited by <term id="T37" lex="ADT" sem="Organic_compound_other">ADT</term> (0.1 mM) pretreatment.</sentence>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<clue>PMA and TNF alpha induced <clueType>activation</clueType> <linkTheme>of</linkTheme> (NF)-kappa B in human Jurkat T-cells was partially inhibited by ADT (0.1 mM) pretreatment.</clue>
</event>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T32"/>
<clue>PMA and TNF alpha <clueType>induced</clueType> activation of (NF)-kappa B <clueLoc>in human Jurkat T-cells</clueLoc> was partially inhibited by ADT (0.1 mM) pretreatment.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T34"/>
<clue>PMA and TNF alpha <clueType>induced</clueType> activation of (NF)-kappa B <clueLoc>in human Jurkat T-cells</clueLoc> was partially inhibited by ADT (0.1 mM) pretreatment.</clue>
</event>
<event KT="Method" id="E25">
<type class="Artificial_process"/>
<theme idref="T37"/>
<clue>PMA and TNF alpha induced activation of (NF)-kappa B in human Jurkat T-cells was partially inhibited by ADT (0.1 mM) <clueType>pretreatment</clueType>.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E25"/>
<clue>PMA and TNF alpha induced activation of (NF)-kappa B in human Jurkat T-cells was partially <clueType>inhibited</clueType> <linkCause>by</linkCause> ADT (0.1 mM) pretreatment.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="E25"/>
<clue>PMA and TNF alpha induced activation of (NF)-kappa B in human Jurkat T-cells was partially <clueType>inhibited</clueType> <linkCause>by</linkCause> ADT (0.1 mM) pretreatment.</clue>
</event>
<sentence id="S8"><term id="T38" lex="ADT" sem="Organic_compound_other">ADT</term> (0.1 mM) also inhibited <term id="T39" lex="H2O2" sem="Inorganic_compound">H2O2</term> induced activation of the <term id="T40" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> in the <term id="T41" lex="peroxide_sensitive_human_Wurzburg_T-cell" sem="Cell_cultured"><term id="A21" sem="Other">peroxide</term> sensitive <term id="A22" sem="Cell_natural">human Wurzburg T-cells</term></term>.</sentence>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="T40"/>
<cause idref="T39"/>
<clue>ADT (0.1 mM) also inhibited H2O2 <linkCause>induced</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> the transcription factor <clueLoc>in the peroxide sensitive human Wurzburg T-cells.</clueLoc></clue>
</event>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="T38"/>
<clue>ADT (0.1 mM) also <clueType>inhibited</clueType> H2O2 induced activation of the transcription factor in the peroxide sensitive human Wurzburg T-cells.</clue>
</event>
<event KT="Other" id="E31">
<type/>
<theme idref="A22"/>
<cause idref="A21"/>
<clue>ADT (0.1 mM) also inhibited H2O2 induced activation of the transcription factor in the peroxide <clueType>sensitive</clueType> human Wurzburg T-cells.</clue>
<comment>SENSITIVITY</comment></event>
<sentence id="S9">Furthermore, <term id="T42" lex="ADT" sem="Organic_compound_other">ADT</term> treated <term id="T43" lex="Wurzburg_cell" sem="Cell_cultured">Wurzburg cells</term> had significantly higher <term id="T44" lex="glutathione_level" sem="Other"><term id="T45" lex="glutathione" sem="Peptide">glutathione</term> levels</term> as compared with <term id="T46" lex="untreated_cell" sem="Cell_natural">untreated cells</term>.</sentence>
<event KT="Method" id="E32">
<type class="Artificial_process"/>
<theme idref="T45"/>
<theme idref="T42"/>
<clue>Furthermore, ADT <clueType>treated</clueType> Wurzburg cells had significantly higher glutathione levels as compared with untreated cells.</clue>
</event>
<event Manner="High" id="E51">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<cause idref="E32"/>
<clue>Furthermore, ADT treated Wurzburg cells <clueType>had</clueType> <clueManner>significantly</clueManner> <clueType><clueManner>higher</clueManner></clueType> glutathione levels as compared with untreated cells.</clue>
</event>
<sentence id="S10"><term id="T47" lex="H2O2" sem="Inorganic_compound">H2O2</term> induced <term id="T48" lex="lipid_peroxidation" sem="Other">lipid peroxidation</term> in <term id="T49" lex="Wurzburg_cell" sem="Cell_cultured">Wurzburg cells</term> was remarkably inhibited by <term id="T50" lex="ADT_pretreatment" sem="Other"><term id="T51" lex="ADT" sem="Organic_compound_other">ADT</term> pretreatment</term>.</sentence>
<event KT="Other" id="E33">
<type class="Positive_regulation"/>
<theme idref="T48"/>
<cause idref="T47"/>
<clue>H2O2 <clueType>induced</clueType> lipid peroxidation <clueLoc>in Wurzburg cells</clueLoc> was remarkably inhibited by ADT pretreatment.</clue>
</event>
<event KT="Method" id="E34">
<type class="Artificial_process"/>
<theme idref="T51"/>
<clue>H2O2 induced lipid peroxidation in Wurzburg cells was remarkably inhibited by ADT <clueType>pretreatment</clueType>.</clue>
</event>
<event id="E35">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="E34"/>
<clue>H2O2 induced lipid peroxidation in Wurzburg cells was remarkably <clueType>inhibited</clueType> <linkCause>by</linkCause> ADT pretreatment.</clue>
</event>
<sentence id="S11"><term id="T52" lex="ADT" sem="Organic_compound_other">ADT</term>, a <term id="T53" lex="pro-_glutathione_antioxidant" sem="Organic_compound_other">pro-<term id="T54" lex="glutathione" sem="Peptide">glutathione</term> <term id="T55" lex="antioxidant" sem="Organic_compound_other">antioxidant</term></term>, was observed to be capable of modulating <term id="T56" lex="NF-kappa_B_activation" sem="Other"><term id="T57" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term>.</sentence>
<event KT="Other" id="E36">
<type class="Positive_regulation"/>
<theme idref="T57"/>
<clue>ADT, a pro-glutathione antioxidant, was observed to be capable of modulating NF-kappa B <clueType>activation</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E37">
<type class="Regulation"/>
<theme idref="E36"/>
<cause idref="T52"/>
<clue>ADT, a <corefCause>pro-glutathione antioxidant</corefCause>, was observed to be <clueKT><clueCL>capable</clueCL></clueKT> of <clueType>modulating</clueType> NF-kappa B activation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
